Abstract: The present disclosure relates to compositions, methods and test devices for determining the presence of active leukocyte cells, for example, by using novel LE and/or HNE substrates in an electrochemical assay.
Type:
Grant
Filed:
September 27, 2018
Date of Patent:
August 31, 2021
Assignee:
CLEU DIAGNOSTICS, LLC
Inventors:
Andrew Neil Fleischman, Javad Parvizi, Ron H. Bihovsky